Marketing-authorisation holder
Monarch Pharmaceuticals Ireland Limited
1 medicine in 1 country, as authorisation holder.
Group structure
Part of
MonarchPharmaceutical groupOther companies in the group
United States1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
1 medicine
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| SYNERCID350 mg / vial + 150 mg / vial · Powder For Solution | Dalfopristin, Quinupristin | Canada | Cancelled | 2000 |